BRIEF published on 07/29/2024 at 12:31, 1 month 18 days ago Sphene Capital Reaffirms 'Buy' Rating for Vidac Pharma Holding BUY Rating Cancer Therapy Sphene Capital Vidac Pharma VDA-1275
BRIEF published on 07/29/2024 at 12:31, 1 month 18 days ago Sphene Capital réaffirme la note « Acheter » de Vidac Pharma Holding Acheter Une Note Thérapie Contre Le Cancer Sphene Capital Vidac Pharma VDA-1275
PRESS RELEASE published on 07/29/2024 at 12:26, 1 month 18 days ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy Update report by Sphene Capital GmbH highlights promising results of VDA-1275 study by Vidac Pharma Holding Plc in cancer treatment. Buy recommendation maintained with EUR 4.90 target price Cancer Treatment Sphene Capital GmbH Vidac Pharma Holding VDA-1275 Study EUR 4.90 Target Price
BRIEF published on 06/12/2024 at 14:41, 3 months 4 days ago Vidac Pharma Holding Plc: Research Initiation by Sphene Capital GmbH with a Buy Rating Oncology BUY Rating Biopharmaceutical Clinical-stage Vidac Pharma
BRIEF published on 06/12/2024 at 14:41, 3 months 4 days ago Vidac Pharma Holding Plc : Initiation d'une recherche par Sphene Capital GmbH avec une note d'achat Biopharmaceutique Oncologie Acheter Une Note Vidac Pharma Stade Clinique
PRESS RELEASE published on 06/12/2024 at 14:36, 3 months 4 days ago Original-Research: Vidac Pharma Holding Plc (von Sphene Capital GmbH): Buy Sphene Capital initiates coverage on Vidac Pharma Holding Plc with a Buy rating and a price target of EUR 4.90. Vidac Pharma focuses on reversing cancer cell metabolism for oncology treatments BUY Rating Sphene Capital GmbH Vidac Pharma Holding Plc Cancer Cell Metabolism Oncology Treatments
Published on 09/16/2024 at 20:15, 39 minutes ago New to the Street's Episode 601 Will Air as Sponsored Programming on Fox Business at 10:30 PM PST, September 16, 2024. This Special Episode Will Feature In-Depth Interviews and Profiles of Industry-Leading Companies Driving Innovation in Their Respective
Published on 09/16/2024 at 20:07, 47 minutes ago Nexera Provides Update#2 on Delayed Filing of Annual Financial Statements and MD&A and Management Cease Trade Order
Published on 09/16/2024 at 20:00, 54 minutes ago Lender Market Unveils AI-Powered Financial Advisor Service for Business Owners
Published on 09/16/2024 at 19:30, 1 hour 24 minutes ago Gabriel Resources Ltd. - Resignation of Director
Published on 09/16/2024 at 19:30, 1 hour 24 minutes ago Gamehost Announces Regular Monthly Dividend for September
Published on 09/16/2024 at 18:32, 2 hours 21 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/16/2024 at 18:19, 2 hours 35 minutes ago BILENDI: Bilendi dévoile 2 projets basés sur son intelligence artificielle générative BARI présentés au congrès mondial ESOMAR
Published on 09/16/2024 at 17:59, 2 hours 54 minutes ago EQS-Adhoc: Airbus reports share buyback transactions 9-13 September 2024
Published on 09/16/2024 at 16:16, 4 hours 38 minutes ago Original-Research: Netfonds AG (von Montega AG): Kaufen
Published on 09/16/2024 at 15:28, 5 hours 26 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 09/16/2024 at 18:00, 2 hours 54 minutes ago Report on the Combined General Meeting of the 12th of September 2024
Published on 09/16/2024 at 18:00, 2 hours 54 minutes ago Compte-rendu d’Assemblée Générale Mixte du 12 septembre 2024
Published on 09/16/2024 at 18:00, 2 hours 54 minutes ago Programme de rachat d’actions propres : Déclaration des transactions sur actions propres réalisées du 9 septembre 2024 au 13 septembre 2024
Published on 09/16/2024 at 18:00, 2 hours 54 minutes ago Share buy-back program: Disclosure of trading in own shares from 9 September 2024 to 13 September 2024
Published on 09/16/2024 at 18:00, 2 hours 54 minutes ago imerys-16-09-2024-communique-capital-droits-de-vote-au-31-juillet-2024